STOCK TITAN

Treatment.com AI Stock Price, News & Analysis

TREIF OTC

Welcome to our dedicated page for Treatment.com AI news (Ticker: TREIF), a resource for investors and traders seeking the latest updates and insights on Treatment.com AI stock.

The TREIF news page aggregates coverage related to Rocket Doctor AI Inc., a healthcare technology company focused on physician-built, AI-powered digital health platforms. Here you can follow announcements about Rocket Doctor AI’s virtual care programs, payer relationships, technology developments, and market activities connected to its AI-driven clinical decision support and digital marketplace.

Rocket Doctor AI’s news frequently highlights the role of its Global Library of Medicine (GLM), a clinically validated decision support system, and its AI-powered platform operated through Rocket Doctor Inc. Updates often describe how over 300 medical doctors have used the platform to deliver hundreds of thousands of virtual or hybrid patient visits, supported by proprietary software, large language models, and connected medical devices.

Investors and observers can expect news items on topics such as virtual care initiatives in Canada and the United States, programs aimed at underserved, rural, and remote communities, and arrangements that support patients on Medicaid and Medicare. Releases also cover partnerships with pharmacies, community organizations, and health systems that integrate Rocket Doctor’s virtual care tools into local settings.

Because Rocket Doctor AI operates within digital health and AI in healthcare, company news often touches on the expansion of virtual care offerings, integration of diagnostic devices, and efforts to reduce administrative burdens for clinicians. This page provides a centralized view of these developments, allowing readers to track how the company’s AI-powered technology and marketplace are being applied across different regions and care settings. Bookmark this page to review new Rocket Doctor AI Inc. (TREIF) news as it becomes available on Stock Titan.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
AI
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.67%
Tags
partnership AI
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.19%
Tags
AI
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.43%
Tags
AI
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
AI
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
private placement AI
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.45%
Tags
management AI
Rhea-AI Summary

Treatment.com International Inc. (CSE: TRUE; OTC: TREIF) is advancing healthcare with its newly launched Treatment Digital Health App, gaining five-star ratings on both Apple and Google platforms. Users, including medical professionals, praise its comprehensive and accurate health assessments. The app is powered by a robust AI-driven Global Library of Medicine, designed to deliver innovative health insights. CEO John Fraser emphasizes the company's commitment to support the medical community and enhance patient care through technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.01%
Tags
AI

FAQ

What is the current stock price of Treatment.com AI (TREIF)?

The current stock price of Treatment.com AI (TREIF) is $0.482 as of August 29, 2025.

What is the market cap of Treatment.com AI (TREIF)?

The market cap of Treatment.com AI (TREIF) is approximately 38.5M.

TREIF Rankings

TREIF Stock Data

38.51M
71.74M
Health Information Services
Healthcare
Link
Canada
Vancouver

TREIF RSS Feed